290 related articles for article (PubMed ID: 10508022)
1. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.
Patick AK; Binford SL; Brothers MA; Jackson RL; Ford CE; Diem MD; Maldonado F; Dragovich PS; Zhou R; Prins TJ; Fuhrman SA; Meador JW; Zalman LS; Matthews DA; Worland ST
Antimicrob Agents Chemother; 1999 Oct; 43(10):2444-50. PubMed ID: 10508022
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.
Zalman LS; Brothers MA; Dragovich PS; Zhou R; Prins TJ; Worland ST; Patick AK
Antimicrob Agents Chemother; 2000 May; 44(5):1236-41. PubMed ID: 10770757
[TBL] [Abstract][Full Text] [Related]
3. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
Matthews DA; Dragovich PS; Webber SE; Fuhrman SA; Patick AK; Zalman LS; Hendrickson TF; Love RA; Prins TJ; Marakovits JT; Zhou R; Tikhe J; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; Brothers MA; DeLisle DM; Worland ST
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11000-7. PubMed ID: 10500114
[TBL] [Abstract][Full Text] [Related]
4. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
[TBL] [Abstract][Full Text] [Related]
5. In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.
Binford SL; Weady PT; Maldonado F; Brothers MA; Matthews DA; Patick AK
Antimicrob Agents Chemother; 2007 Dec; 51(12):4366-73. PubMed ID: 17908951
[TBL] [Abstract][Full Text] [Related]
6. In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.
Patick AK; Brothers MA; Maldonado F; Binford S; Maldonado O; Fuhrman S; Petersen A; Smith GJ; Zalman LS; Burns-Naas LA; Tran JQ
Antimicrob Agents Chemother; 2005 Jun; 49(6):2267-75. PubMed ID: 15917520
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses.
Kaiser L; Crump CE; Hayden FG
Antiviral Res; 2000 Sep; 47(3):215-20. PubMed ID: 10974374
[TBL] [Abstract][Full Text] [Related]
9. Development of potent inhibitors of the coxsackievirus 3C protease.
Lee ES; Lee WG; Yun SH; Rho SH; Im I; Yang ST; Sellamuthu S; Lee YJ; Kwon SJ; Park OK; Jeon ES; Park WJ; Kim YC
Biochem Biophys Res Commun; 2007 Jun; 358(1):7-11. PubMed ID: 17485072
[TBL] [Abstract][Full Text] [Related]
10. Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design.
Yuan S; Fan K; Chen Z; Sun Y; Hou H; Zhu L
Virol Sin; 2020 Aug; 35(4):445-454. PubMed ID: 32103448
[TBL] [Abstract][Full Text] [Related]
11. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
[TBL] [Abstract][Full Text] [Related]
12. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
[TBL] [Abstract][Full Text] [Related]
13. Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation.
Reich SH; Johnson T; Wallace MB; Kephart SE; Fuhrman SA; Worland ST; Matthews DA; Hendrickson TF; Chan F; Meador J; Ferre RA; Brown EL; DeLisle DM; Patick AK; Binford SL; Ford CE
J Med Chem; 2000 May; 43(9):1670-83. PubMed ID: 10794684
[TBL] [Abstract][Full Text] [Related]
14. Peptidyl diazomethyl ketones inhibit the human rhinovirus 3C protease: effect on virus yield by partial block of P3 polyprotein processing.
Murray MA; Janc JW; Venkatraman S; Babé LM
Antivir Chem Chemother; 2001 Sep; 12(5):273-81. PubMed ID: 11900346
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93.
Costenaro L; Kaczmarska Z; Arnan C; Janowski R; Coutard B; Solà M; Gorbalenya AE; Norder H; Canard B; Coll M
J Virol; 2011 Oct; 85(20):10764-73. PubMed ID: 21835784
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics.
Dragovich PS; Prins TJ; Zhou R; Johnson TO; Brown EL; Maldonado FC; Fuhrman SA; Zalman LS; Patick AK; Matthews DA; Hou X; Meador JW; Ferre RA; Worland ST
Bioorg Med Chem Lett; 2002 Mar; 12(5):733-8. PubMed ID: 11858991
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease.
Johnson TO; Hua Y; Luu HT; Brown EL; Chan F; Chu SS; Dragovich PS; Eastman BW; Ferre RA; Fuhrman SA; Hendrickson TF; Maldonado FC; Matthews DA; Meador JW; Patick AK; Reich SH; Skalitzky DJ; Worland ST; Yang M; Zalman LS
J Med Chem; 2002 May; 45(10):2016-23. PubMed ID: 11985469
[TBL] [Abstract][Full Text] [Related]
18. Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells
Kitano M; Hosmillo M; Emmott E; Lu J; Goodfellow I
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530860
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies.
Dragovich PS; Webber SE; Babine RE; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Reich SH; Prins TJ; Marakovits JT; Littlefield ES; Zhou R; Tikhe J; Ford CE; Wallace MB; Meador JW; Ferre RA; Brown EL; Binford SL; Harr JE; DeLisle DM; Worland ST
J Med Chem; 1998 Jul; 41(15):2806-18. PubMed ID: 9667970
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors.
Dragovich PS; Zhou R; Webber SE; Prins TJ; Kwok AK; Okano K; Fuhrman SA; Zalman LS; Maldonado FC; Brown EL; Meador JW; Patick AK; Ford CE; Brothers MA; Binford SL; Matthews DA; Ferre RA; Worland ST
Bioorg Med Chem Lett; 2000 Jan; 10(1):45-8. PubMed ID: 10636240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]